Atossa Therapeutics, Inc.

ATOS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$71,084$88,460$110,890$136,377
Short-Term Investments$0$0$0$0
Receivables$0$0$0$1,072
Inventory$0$1,487$5,247$0
Other Curr. Assets$3,373$2,272$2,060$3,791
Total Curr. Assets$74,457$92,219$118,197$141,240
Property Plant & Equip (Net)$0$0$0$20
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$1,710$4,700$0
Tax Assets$0$0$0$0
Other NC Assets$1,987$2,323$635$2
Total NC Assets$1,987$4,033$5,335$22
Other Assets$0$0$0$0
Total Assets$76,444$96,252$123,532$141,262
Liabilities
Payables$679$806$2,965$1,717
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,288$4,430$2,603$1,409
Total Curr. Liab.$4,967$5,236$5,568$3,126
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$4,967$5,236$5,568$3,126
Equity
Pref Stock$0$0$0$0
Common Stock$23,488$22,792$22,792$22,792
Retained Earnings-$211,792-$186,288-$156,194-$129,234
AOCI$0$0-$0$0
Other Equity$259,781$254,512$251,366$244,578
Total Equity$71,477$91,016$117,964$138,136
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$76,444$96,252$123,532$141,262
Net Debt-$71,084-$88,460-$110,890-$136,377